Duearity
0,402 SEK +3,21%1 investor følger denne virksomhed
Duearity operates in the medical technology industry. The company specializes in the development and production of technical solutions for the treatment and relief of tinnitus. The product portfolio includes, for example, the company's proprietary products Tinearity and Duearity. In addition to the main business, service and associated ancillary services are also offered. Duearity operates on the Swedish market.
Omsætning
970 t
EBIT %
-2.135,05 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
DEAR
Daglig lav / høj pris
0,351 / 0,402
SEK
Markedsværdi
10,59 mio. SEK
Aktieomsætning
18,39 t SEK
Volumen
47 t
Seneste videoer
Finanskalender
Delårsrapport
16.05.2024
Generalforsamling
03.06.2024
Delårsrapport
22.08.2024
Delårsrapport
28.11.2024
Årsrapport
27.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Footloose Invest AB | 33,7 % | 33,7 % |
JeGol Group AB | 13,7 % | 13,7 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Clinics in the US can now purchase Tinearity G1 through a national trading platform
Eminova Partners day - Duearity
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools